CIK 0001162194 · Accelerated filer
STANDARD BIOTOOLS INC.
Sign in to watch- Ticker
- LAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770513190
- Phone
- 6502666000
- Business address
- 50 MILK STREET, 10TH FLOOR, BOSTON, MA, 02109
- Former names
- FLUIDIGM CORP
- Open-market buys, last 90 days
- $46,898
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$46,898. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-04 | Egholm Michael President & CEO | Option exercise · Restricted Stock Units | −196,512 | 196,513 | ||
| 2025-04-04 | Kim Hanjoon Alex Chief Financial Officer | Option exercise | +70,183 | 962,281 | ||
| 2025-04-04 | Kim Hanjoon Alex Chief Financial Officer | Shares withheld for taxes | −21,441 | $1.07 | $23K | 940,840 |
| 2025-04-04 | Kim Hanjoon Alex Chief Financial Officer | Option exercise · Restricted Stock Units | −70,183 | 70,183 | ||
| 2025-03-21 | Kim Hanjoon Alex Chief Financial Officer | Grant or award | +338,333 | 892,098 | ||
| 2025-03-21 | Kim Hanjoon Alex Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +507,500 | 507,500 | ||
| 2025-03-21 | Mackay Sean SVP & Chief Business Officer | Grant or award | +281,667 | 881,667 | ||
| 2025-03-21 | Mackay Sean SVP & Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +422,500 | 422,500 | ||
| 2025-03-21 | Egholm Michael President & CEO | Grant or award | +1,188,333 | 2,636,006 | ||
| 2025-03-21 | Egholm Michael President & CEO | Grant or award · Stock Option (Right to buy) | +1,782,500 | 1,782,500 | ||
| 2025-02-28 | Carey Thomas D. Director | Grant or award | +56,338 | $1.07 | $60K | 99,466 |
| 2025-02-28 | Cox Troy Director | Grant or award | +62,910 | $1.07 | $67K | 224,730 |
| 2025-02-28 | Casdin Partners Master Fund, L.P. Director | Purchase | +4,820,959 | $1.07 | $5.1M | 58,846,780 |
| 2025-02-28 | Casdin Partners Master Fund, L.P. Director | Other acquisition | +545,000 | $1.07 | $580K | 59,391,780 |
| 2025-02-28 | Casdin Partners Master Fund, L.P. Director | Other disposition | −545,000 | $1.07 | $580K | 0 |
| 2025-02-28 | Casdin Partners Master Fund, L.P. Director | Grant or award | +58,215 | $1.07 | $62K | 2,806,470 |
| 2025-02-20 | Egholm Michael President & CEO | Shares withheld for taxes | −31,031 | $1.39 | $43K | 1,447,673 |
| 2024-11-20 | Egholm Michael President & CEO | Shares withheld for taxes | −28,795 | $1.51 | $43K | 1,473,704 |
| 2024-08-27 | Casdin Partners Master Fund, L.P. Director | Purchase | +250,000 | $2.19 | $547K | 54,025,821 |
| 2024-08-26 | Casdin Partners Master Fund, L.P. Director | Purchase | +150,000 | $2.15 | $322K | 53,775,821 |
Page 6 of 9 · 179 trades